Below are the financial statements of Alibaba Health, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
All figures in millions of CNY | 2024 | 2023 |
---|---|---|
Revenue | 27,026.56a | 26,763.02a |
Cost of sales | -21,131.23a | -21,061.68a |
Gross profit | 5,895.32a | 5,701.33a |
Other income and gains | 674.76a | 618.07a |
Operating expenses | — | — |
Fulfilment | -2,413.21a | -2,907.14a |
Selling and marketing expenses | -1,776.56a | -1,768.68a |
Administrative expenses | -359.98a | -379.49a |
Product development expenses | -705.38a | -677.82a |
Other expenses and losses | -363.64a | -40.84a |
Finance costs | -5.97a | -5.83a |
Share of profits/(losses) of | — | — |
Joint ventures | 1.04a | 48.98a |
Associates | -6.97a | -37.6a |
Profit before tax | 939.4a | 550.99a |
Income tax expense | -56.26a | -14.49a |
Profit for the year | 883.14a | 536.51a |
Attributable to | — | — |
Owners of the parent | 883.48a | 535.65a |
Non-controlling interests | -0.34a | 0.86a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Alibaba Health’s data sources below and access millions more through our Disclosure Search.